2,851
edits
No edit summary |
|||
Line 3: | Line 3: | ||
Although trimethylglycine supplementation decreases the amount of [[wikipedia:Adipose_tissue|adipose tissue]] in pigs, research on human subjects has shown no effect on body weight, body composition, or resting energy expenditure when used in conjunction with a low calorie diet.<ref name="pmid12399266">{{cite journal|last1=Schwab|volume=76|doi-access=free|doi=10.1093/ajcn/76.5.961|pmid=12399266|date=November 2002|pages=961–967|issue=5|journal=Am. J. Clin. Nutr.|first1=U.|title=Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects|display-authors=etal|first3=L.|last3=Toppinen|first2=A.|last2=Törrönen|title-link=doi}}</ref> | Although trimethylglycine supplementation decreases the amount of [[wikipedia:Adipose_tissue|adipose tissue]] in pigs, research on human subjects has shown no effect on body weight, body composition, or resting energy expenditure when used in conjunction with a low calorie diet.<ref name="pmid12399266">{{cite journal|last1=Schwab|volume=76|doi-access=free|doi=10.1093/ajcn/76.5.961|pmid=12399266|date=November 2002|pages=961–967|issue=5|journal=Am. J. Clin. Nutr.|first1=U.|title=Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects|display-authors=etal|first3=L.|last3=Toppinen|first2=A.|last2=Törrönen|title-link=doi}}</ref> | ||
= | = Positiv Effects = | ||
Protective effects of TMG in experimental animal models, cell culture systems, and clinical studies. | Protective effects of TMG in experimental animal models, cell culture systems, and clinical studies. | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="1" rowspan="1" |Therapeutic Effects of TMG Administration | ! colspan="1" rowspan="1" |Therapeutic Effects of TMG Administration | ||
Line 10: | Line 10: | ||
! colspan="1" rowspan="1" |Authors | ! colspan="1" rowspan="1" |Authors | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Prevents hepatic fat accumulation in ALD | ||
| colspan="1" rowspan="1" |Male Wistar rats; C57BL/6 mice; Balb/c mice | | colspan="1" rowspan="1" |Male Wistar rats; C57BL/6 mice; Balb/c mice | ||
| colspan="1" rowspan="1" |[23,27,83,115,121,157,158,160] | | colspan="1" rowspan="1" |[23,27,83,115,121,157,158,160] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Preserves/restores hepatic SAM: SAH ratios by regenerating SAM and lowering SAH and homocysteine levels in ALD | ||
| colspan="1" rowspan="1" |Male Wistar rats; hepatocytes; male C57BL/6 mice | | colspan="1" rowspan="1" |Male Wistar rats; hepatocytes; male C57BL/6 mice | ||
| colspan="1" rowspan="1" |[23,60,61,81,82,83,84,86,88,91,92,117,119,121,234,235] | | colspan="1" rowspan="1" |[23,60,61,81,82,83,84,86,88,91,92,117,119,121,234,235] | ||
Line 22: | Line 22: | ||
| colspan="1" rowspan="1" |[23,90,91,92] | | colspan="1" rowspan="1" |[23,90,91,92] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Suppresses the synthesis of DGAT2, a rate-limiting enzyme in triglyceride synthesis, by alleviating ERK1/2 inhibition in ALD | ||
| colspan="1" rowspan="1" |Male C57BL/6 mice | | colspan="1" rowspan="1" |Male C57BL/6 mice | ||
| colspan="1" rowspan="1" |[121] | | colspan="1" rowspan="1" |[121] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Upregulates antioxidant defense system and improves oxyradical scavenging activity in ALD | ||
| colspan="1" rowspan="1" |Male Wistar rats | | colspan="1" rowspan="1" |Male Wistar rats | ||
| colspan="1" rowspan="1" |[133] | | colspan="1" rowspan="1" |[133] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Prevents/attenuates ER stress in ALD | ||
| colspan="1" rowspan="1" |Male C57BL/6 mice | | colspan="1" rowspan="1" |Male C57BL/6 mice | ||
| colspan="1" rowspan="1" |[83] | | colspan="1" rowspan="1" |[83] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Exerts hepatoprotection by preserving mitochondrial function in ALD | ||
| colspan="1" rowspan="1" |Male Wistar rats | | colspan="1" rowspan="1" |Male Wistar rats | ||
| colspan="1" rowspan="1" |[61] | | colspan="1" rowspan="1" |[61] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Restores the serum adiponectin levels in ALD | ||
| colspan="1" rowspan="1" |Mice | | colspan="1" rowspan="1" |Mice | ||
| colspan="1" rowspan="1" |[123] | | colspan="1" rowspan="1" |[123] | ||
Line 46: | Line 46: | ||
| colspan="1" rowspan="1" |[115,133] | | colspan="1" rowspan="1" |[115,133] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Prevents serum ALT and AST activity elevations in models of ALD and MAFLD | ||
| colspan="1" rowspan="1" |Male Wistar rats | | colspan="1" rowspan="1" |Male Wistar rats | ||
| colspan="1" rowspan="1" |[27,115,121] | | colspan="1" rowspan="1" |[27,115,121] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Reduces liver oxidant stress, inflammation, and apoptosis in MAFLD | ||
| colspan="1" rowspan="1" |Male C57BL/6 mice | | colspan="1" rowspan="1" |Male C57BL/6 mice | ||
| colspan="1" rowspan="1" |[28] | | colspan="1" rowspan="1" |[28] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Remethylates homocysteine, protecting from oxidant stress and restoring phosphatidylcholine generation in MAFLD | ||
| colspan="1" rowspan="1" |C57BL/6 mice | | colspan="1" rowspan="1" |C57BL/6 mice | ||
| colspan="1" rowspan="1" |[161] | | colspan="1" rowspan="1" |[161] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Stimulates β-oxidation in livers of MCD diet-induced MAFLD | ||
| colspan="1" rowspan="1" |Male Sprague-Dawley rats | | colspan="1" rowspan="1" |Male Sprague-Dawley rats | ||
| colspan="1" rowspan="1" |[162] | | colspan="1" rowspan="1" |[162] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Alleviates steatosis and increases autophagosomes numbers in mouse livers with MAFLD | ||
| colspan="1" rowspan="1" |Male C57BL/6 mice; rats | | colspan="1" rowspan="1" |Male C57BL/6 mice; rats | ||
| colspan="1" rowspan="1" |[120,161] | | colspan="1" rowspan="1" |[120,161] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Enhances the conversion of existing WAT to brown adipose tissue through stimulating mitochondrial biogenesis in MAFLD | ||
| colspan="1" rowspan="1" |Mice | | colspan="1" rowspan="1" |Mice | ||
| colspan="1" rowspan="1" |[203] | | colspan="1" rowspan="1" |[203] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Alleviates ROS-induced mitochondrial respiratory chain dysfunction in MAFLD | ||
| colspan="1" rowspan="1" |Male Sprague-Dawley rats | | colspan="1" rowspan="1" |Male Sprague-Dawley rats | ||
| colspan="1" rowspan="1" |[163]. | | colspan="1" rowspan="1" |[163]. | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Attenuates different grades of steatosis, inflammation, and fibrosis in MAFLD patients | ||
| colspan="1" rowspan="1" |Human trials | | colspan="1" rowspan="1" |Human trials | ||
| colspan="1" rowspan="1" |[45,165,166,167] | | colspan="1" rowspan="1" |[45,165,166,167] | ||
|- | |- | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" |Prevents adipose tissue dysfunction in ALD | ||
| colspan="1" rowspan="1" |Male C57BL/6 mice | | colspan="1" rowspan="1" |Male C57BL/6 mice | ||
| colspan="1" rowspan="1" |[194] | | colspan="1" rowspan="1" |[194] |